1
/
of
0
FDA Drug/Biologics Approval BLA 125472 S-018, TOCILIZUMAB
FDA Drug/Biologics Approval BLA 125472 S-018, TOCILIZUMAB
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
BLA 125472 S-018
Company: GENENTECH
Drug Name: ACTEMRA
Active Ingredients: TOCILIZUMAB
Strength: 162MG/0.9ML
Dosage Form/Route: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Action Date: 10/21/2013
Marketing Status: Prescription
Submission Classification: ORIG-1
Company: GENENTECH
Drug Name: ACTEMRA
Active Ingredients: TOCILIZUMAB
Strength: 162MG/0.9ML
Dosage Form/Route: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS
Action Date: 10/21/2013
Marketing Status: Prescription
Submission Classification: ORIG-1
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details